Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
Zsebo, Krisztina (Celladon Corp 201411 CEO) |
Chief Executive Officer (CEO) |
Celladon Corporation |
United States (USA) |
Zuber, Johannes (IMP Vienna 2011– Group Leader + Quantro Therapeutics 202007 Co-Founder + Scientific Advisor) |
Researcher (university / research institute) |
Boehringer Ingelheim (Group) |
Austria |
Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Switzerland |
Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
Zuckerman, Linda (Evotec 202209 EVP Global Head Biotherapeutics at Just – Evotec Biologics) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
Zuliani, Vincent (GenoSafe 201611 Business Development Director) |
Business Development Manager / Strategy Manager |
GenoSafe SAS |
France |
Zumbansen, Markus (Ayoxxa 201407– VP RnD before Miltenyi Biotec) |
Research & Development Manager |
Ayoxxa (Group) |
Germany |
Zumbrum, Michael (AllPure Technologies 201404 President) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
United States (USA) |
Zundel, Stefan (Dopavision 201809– Managing Director + Co-Founder) |
Managing Director |
Dopavision GmbH |
Germany |
zur Hausen, Harald |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
zur Hausen, Jan Dirk (Bergmann zur Hausen 201210 Managing Director + Co-founder) |
Managing Director |
Bergmann zur Hausen & Cie. GmbH |
Germany |
Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
Zurek Gabriela (Bruker Biosciences 2006 Bruker Daltonik GmbH Application Scientist) |
n. a. |
Bruker (Group) |
Germany |
Zurlo, Alfredo (Glycotope 201604– CMO before Mologen 201304– CMO before Roche + EORTC) |
Chief Medical Officer (CMO) |
Glycotope (Group) |
Germany |
Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic) |
Business Development Manager / Strategy Manager |
Mirador Therapeutics Inc. |
United States (USA) |
Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
Zündorf, Peter (Schering 2005– before Aventis Pharma before RPR + Bayer) |
n. a. |
Bayer (Group) |
Germany |
Zünkeler, Martin (Kairos GmbH 201203 Managing Director) |
Managing Director |
Iqvia (Group) |
Germany |
Zypries, Brigitte (Germany (govt) 200809 Minister of Justice) |
Minister |
Germany (govt) |
Germany |
Zywottek, Walter W. (Merck KGaA –200807 before VWR president and CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
Zätzsch, Jörg (CMS Hasche Sigle 200809 Berlin) |
Attorney / Lawyer |
CMS (Group) |
Germany |
Zöchbauer, Emmerich (BIA Separations 201509 Chair Board of BIA Separations Austria) |
Board member, executive |
Sartorius (Group) |
Austria |
Zöllner, E. Jürgen (Stiftung Charité 201209 Board Member) |
n. a. |
Stiftung Charité |
Germany |
Zörgiebel, Wilhelm (Willi) (Biotype Diagnostic 201107 Managing Director + Owner before Priontype) |
Managing Director |
Qiagen (Group) |
Germany |
Åström, Håkan |
Board member |
Affibody Medical AB |
Sweden |
Ölschläger, Uwe (Qiagen 200904) |
n. a. |
Qiagen (Group) |
Germany |
Štrancar, Aleš (BIA Separations 201309 CEO + Chief Business Development Officer) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Slovenia |
Šušteric, Jakob (MESI 202306 CEO) |
Chief Executive Officer (CEO) |
MESI (Group) |
Slovenia |
Žmuc, Dora (Patronus Health 202204 Managing Director + Chief Business Development Officer + Co-Founder) |
Business Development Manager / Strategy Manager |
Patronus Health GmbH |
Germany |
Ørnskov, Flemming (Shire 201301– CEO before Bayer Chief Marketing Officer + Bausch & Lomb + Ikaria + Novartis) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Ireland, Republic of |
Ørum, Henrik (Santaris Pharma 200712 CSO + VP BusDev) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Denmark |
Øystein, Soug (Polaris 201506 announced as CFO before Algeta + Orcla) |
Chief Financial Officer (CFO) |
Polaris (NO) (Group) |
Norway |